Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vitali Pool

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of the Pediatric Infectious Diseases Society|February 14, 2018
Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous DoseScott A Halperin, Catherine Donovan, Gary S Marshall, et al.
Pediatrics|November 29, 2002
Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United StatesVitali Pool, M Miles Braun, John M Kelso, et al.
Vaccine|May 12, 2007
Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety dataRobert P Wise, Jan Bonhoeffer, Judy Beeler, et al.
The Pediatric Infectious Disease Journal|August 22, 2021
Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis VaccinationJohn Hansen, Michael D Decker, Edwin Lewis, et al.
Vaccine|April 9, 2023
Prenatal tetanus-diphtheria-acellular pertussis vaccine effectiveness at preventing infant pertussisJuan C Vargas-Zambrano, Liana R Clark, David R Johnson, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|June 27, 2003
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001Weigong Zhou, Vitali Pool, John K Iskander, et al.
Vaccine|November 19, 2017
Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety dataElizabeth P Schlaudecker, Flor M Munoz, Azucena Bardají, et al.
Vaccine|July 25, 2016
Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataJayani Pathirana, Flor M Muñoz, Victoria Abbing-Karahagopian, et al.
Vaccine|April 24, 2007
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataJens U Rüggeberg, Michael S Gold, José-Maria Bayas, et al.
Vaccine|November 19, 2017
Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataSarah Rae Easter, Linda O Eckert, Nansi Boghossian, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of the Pediatric Infectious Diseases Society|February 14, 2018
Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous DoseScott A Halperin, Catherine Donovan, Gary S Marshall, et al.
Pediatrics|November 29, 2002
Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United StatesVitali Pool, M Miles Braun, John M Kelso, et al.
Vaccine|May 12, 2007
Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety dataRobert P Wise, Jan Bonhoeffer, Judy Beeler, et al.
The Pediatric Infectious Disease Journal|August 22, 2021
Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis VaccinationJohn Hansen, Michael D Decker, Edwin Lewis, et al.
Vaccine|April 9, 2023
Prenatal tetanus-diphtheria-acellular pertussis vaccine effectiveness at preventing infant pertussisJuan C Vargas-Zambrano, Liana R Clark, David R Johnson, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|June 27, 2003
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001Weigong Zhou, Vitali Pool, John K Iskander, et al.
Vaccine|November 19, 2017
Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety dataElizabeth P Schlaudecker, Flor M Munoz, Azucena Bardají, et al.
Vaccine|July 25, 2016
Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataJayani Pathirana, Flor M Muñoz, Victoria Abbing-Karahagopian, et al.
Vaccine|April 24, 2007
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataJens U Rüggeberg, Michael S Gold, José-Maria Bayas, et al.
Vaccine|November 19, 2017
Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataSarah Rae Easter, Linda O Eckert, Nansi Boghossian, et al.
Pageof 3